Abbvie.Com

board Add to my board

Company

select Filter
All
Business
Culture
Environment
Health
Politics
Research

Key facts

Latest news (see all)

AbbVie taps longtime executive Robert Michael as new CEO, succeeding Richard Gonzalez

Read: CNBC News

2024-02-20

$19 Billion in a Week: AbbVie Makes Two Big Bets

Read: The Wall Street Journal

2023-12-08

$19 Billion in a Week: AbbVie Makes Two Big Bets

Read: The Wall Street Journal

2023-12-08

AbbVie to acquire neuroscience drugmaker Cerevel Therapeutics for $8.7 billion

Read: CNBC News

2023-12-07

AbbVie to Buy Cerevel Therapeutics for $8.7 Billion

Read: The Wall Street Journal

2023-12-06

AbbVie has agreed to buy biotech ImmunoGen for $10.1 billion in a bet on a promising novel drug technology for attacking cancer.

Read: The Wall Street Journal

2023-12-01

Biotech stocks jump on AbbVie deal to buy cancer drugmaker ImmunoGen for $10 billion

Read: CNBC News

2023-11-30

Metrics

Business

assets 146.5B $
Debt 73.2B $
free cash flow 18,629,400,000.00
market cap 245,429,000,000.00
profits 11.5B $


Visualizations

Datasets

Source

Twitter, YAHOO-FIN, YFINANCE

Updated: 2 days ago

License

CC BY 4.0

Going further

dark About